Interpretation of bedaquiline medical insurance policy

Bedaquiline, an innovative anti-tuberculosis drug specially designed for multidrug-resistant tuberculosis (MDR-TB), has been developed since

In clinical practice, bedaquiline is usually used in combination with other anti-tuberculosis drugs, with a treatment course of approximately 24 weeks (i.e. 6 months). Research data shows that the addition of bedaquiline can not only significantly shorten the treatment cycle of tuberculosis, but also further improve the cure rate of multidrug-resistant tuberculosis. However, as a powerful drug, bedaquiline should be used with caution as it may cause some adverse reactions, such as prolonged QT interval (increasing the risk of abnormal heart rhythm), abnormal liver function, headache and nausea, etc. Therefore, patients must be under the strict supervision of doctors and undergo regular electrocardiogram and liver function tests during treatment to ensure the safety of treatment.

For the majority of patients, bedaquiline’s medical insurance policy is undoubtedly a major benefit. At present, bedaquiline has been successfully launched in China and has been included in the national medical insurance directory, which has greatly reduced the financial burden on patients. In the domestic market, the common specifications are 100mg*24 tablets, and the price per box is about six to seven thousand yuan. However, after being included in medical insurance, the actual payment of patients will be significantly reduced. The specific reimbursement ratio and final price need to be determined according to the local medical insurance policy and the relevant regulations of the hospital pharmacy. Since there are regional differences in medical insurance reimbursement policies, patients are advised to consult local hospitals or medical insurance departments in detail to obtain the most accurate information.

In addition, it is worth noting that the price of bedaquiline on the international market varies greatly. For example, the Russian version of the original drug 100mg 188 tablets costs about more than 10,000 yuan, which is more affordable than domestic prices. The Indian generic drug 100mg 188 tablets are even cheaper, costing only more than 2,000 yuan, and the drug ingredients are basically the same as the original drug. However, for patients considering purchasing medications from overseas, it is important to pay attention to the reliability of the source and safety of use.